Nasopharyngeal Carcinoma — Trials

Nasopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 246
Recruiting: 131
Ph III recruiting: 54
Growth YoY: +5.4%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 22.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06770699	Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma	active not recruiting	—	260	Jiangxi Provincial Cancer HospitalOTHER	1	Jan 13, 2025	clinicaltrials
NCT05869227	Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma	active not recruiting	Phase 3	166	XIANG YANQUNOTHER	1	Dec 30, 2024	clinicaltrials